{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-130480","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2026-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.391080+00:00","generated_at":"2026-05-15T08:23:08.129101+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"confidence":"high","headline":"Tempest FY2025 net loss $26.3M; cash $7.7M; completed CAR-T acquisition","bullets":["Net loss improved to $26.3M ($6.33/share) vs $41.8M ($19.50/share) in 2024.","Cash at $7.7M at Dec 31, 2025, down from $30.3M at Dec 31, 2024.","Completed all-stock acquisition of CAR-T assets from Factor Bioscience, including clinical-stage TPST-2003.","TPST-2003 showed 100% CR in 6 evaluable rrMM patients; median PFS 23.1 months in prior IIT.","Raised $2M upfront in March 2026 private placement with up to $4M additional from warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-130480","json":"https://secwatch.observer/filing/0001193125-26-130480.json","markdown":"https://secwatch.observer/filing/0001193125-26-130480.md","text":"https://secwatch.observer/filing/0001193125-26-130480.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526130480/0001193125-26-130480-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526130480/tpst-20260330.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:23:08.129101+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}